Tiny movements, big impact? hourly activity program aims to protect rural Women's hearts

NCT ID NCT07704749

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This pilot study tests whether a simple program of brief, frequent movement throughout the day can help reduce cardiometabolic risk in rural women. Participants wear a Fitbit that reminds them to move each hour and complete health assessments before and after the 12-week program. The study focuses on whether the program is feasible to run in routine clinic care and looks for early signs of improvement in risk factors like blood pressure and waist circumference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 12-week program of brief, frequent light-to-moderate movement each waking hour, supported by a Fitbit Inspire 3 activity tracker with hourly reminders
What this could lead to
If successful, this approach could offer a simple, scalable way to prevent heart disease and diabetes in rural women who face barriers to traditional exercise programs.
What could go wrong
This is a small, single-group pilot study with no comparison group, so results may not prove the program works. Adherence to hourly movement may be challenging for some participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC RISK FACTORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Texas Tech University Health Sciences Center Clinical Research Institute

    Lubbock, Texas, 79430, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.